【0】Society guideline links: Polyarteritis nodosa
Introduction 

【1】This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

【2】Links to related guidelines are provided separately.

【3】International

【4】 European League Against Rheumatism (EULAR)/Paediatric Rheumatology International Trials Organisation (PRINTO)/Paediatric Rheumatology European Society (PRES): Criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis – Part I: Overall methodology and clinical characterisation 

【5】 EULAR/PRINTO/PRES: Criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis – Part II: Final classification criteria 

【6】United States

【7】 American College of Rheumatology (ACR)/Vasculitis Foundation (VF): Guideline for the management of polyarteritis nodosa 

【8】Europe

【9】 European League Against Rheumatism (EULAR): Recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases, update 

【10】 EULAR/European Vasculitis Study Group (EUVAS): Points to consider in the development of classification and diagnostic criteria in systemic vasculitis 

【11】 EULAR/EUVAS: Recommendations for the management of vasculitis 

【12】 EULAR/Paediatric Rheumatology International Trials Organisation (PRINTO)/Paediatric Rheumatology European Society (PRES): Criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis – Part I: Overall methodology and clinical characterisation 

【13】 EULAR/PRINTO/PRES: Criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis – Part II: Final classification criteria 

【14】Japan

【15】 \[In Japanese\] Japanese Dermatological Association (JDA): Guidelines for the treatment of vasculitis and vascular disorders 

【16】 \[In English\] Japanese Circulation Society (JCS): Guideline for management of vasculitis syndrome – Digest version 

【17】Topic 121058 Version 9.0黄艳玲

====================================================================================================
